— Know what they know.
Not Investment Advice

GXH.NZ NZE

Green Cross Health Limited
1W: +0.0% 1M: +2.1% 3M: +1.5% YTD: +42.5% 1Y: +137.5% 3Y: +80.0% 5Y: +182.9%
NZ$1.92 ($1.07)
-0.06 (-3.03%)
 
Weekly Expected Move ±5.0%
NZ$2 NZ$2 NZ$2 NZ$2 NZ$2
NZE · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 54 · NZ$284.8M mcap · 32M float · 0.090% daily turnover

Cash Flow Trends

Operating Cash Flow
$53M +0.7% ▲
5Y CAGR: -5.4%
Capital Expenditures
$10M -64.6% ▼
5Y CAGR: +14.1%
Free Cash Flow
$43M -7.3% ▼
5Y CAGR: -7.7%
Dividends Paid
$8M +8.3% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$2M -21.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$20M$15M$12M$0$20M
Depreciation & Amort.$23M$22M$21M$0$21M
Stock-Based Comp.$90K$194K$100K$0$0
Change in Working Capital-$2M-$10M$2M$2M-$680K
Other Non-Cash Items$73M$72M$11M$51M$13M
Operating Cash Flow$65M$44M$46M$53M$53M
— Investing Activities —
Capital Expenditures-$4M-$6M-$7M-$6M-$10M
Acquisitions (Net)-$18M-$16M-$10M-$1M-$1M
Investment Purchases-$725K-$3M-$323K-$127K-$273K
Investment Sales$0$0$0$0$0
Other Investing-$2M$30M-$276K$0$0
Investing Cash Flow-$25M$5M-$18M-$7M-$11M
— Financing Activities —
Net Debt Issuance-$653K-$15M-$1M-$11M-$5M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$4M-$10M-$49M-$9M-$8M
Other Financing-$24M-$15M-$11M-$23M-$27M
Financing Cash Flow-$29M-$40M-$61M-$43M-$39M
Net Change in Cash$8M$13M-$35M$3M$2M
Cash End of Period$45M$58M$23M$26M$28M
Free Cash Flow$61M$39M$36M$47M$43M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms